The new report provides unprecedented transparency into these practices and not only exposes how the current system enables monopolization but also illustrates how these strategies are part of a larger, financially driven business model that prioritizes shareholder returns over public health
Toxicol Sci 113, 25466
Gastrointestinal issues: Nausea, constipation, reflux, and dry mouth are among the most common reasons people discontinue GLP-1 therapy
4.3 Nervous system disorder Recently, a protective effect of the GLP-1/GLP-1R axis on ischemic brain injury has been emphasized
Bs practice, BPC-157 is available in oral capsule form, making it accessible and straightforward to incorporate into a daily routine
Its expression is closely associated with markers of renal stress and fibrosis, highlighting its potential utility in the early identification of patients at high risk of CKD progression